Dextropropoxyphene Hydrochloride

盐酸右丙氧芬

Report date: 2022/08/17 14:43:15
NME

Base Information

Drug NameDextropropoxyphene Hydrochloride
Drug Alias Name盐酸丙氧芬Dextropropoxifeno右丙氧芬盐酸盐Propoxyphene HydrochlorideAntalvic +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors agonists
TargetsOpioid receptors
Therapy Area/IndicationsPain
Global Approved IndicationsPain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1957/08/16
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaDiscontinued
Originator CompaniesXanodyne
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXanodyne Pharmaceuticals IncNeimenggu Tianxingjian Pharmaceutical Technology Development Co Ltd
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN02AC04
Related LinksN/A